Figure 1
From: Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
Flow chart of 264 eyes (229 patients) with neovascular age-related macular degeneration at a university medical centre in 2012–2014 for which an application was made to the national health insurance system in Taiwan for funding of treatment with ranibizumab.
